Knockdown of SUV39H2 in these two cell lines significantly decreased cell viability, compared to those treated with siNC (Figure 1E), suggesting that SUV39H2 plays a critical role in breast cancer cell growth. This evidence concerns the gene SUV39H2 and breast cancer.